Assistant Professor, Harvard Medical School
Dr. Omar Abudayyeh is a recipient of the 2024 Michelson Prizes: Next Generation Grants for his proposal, “Development of Programmable RNA Sensors for Next-Generation Cancer Immunotherapies.”
Dr. Abudayyeh is an assistant professor at Harvard Medical School, investigator at Brigham and Women’s Hospital and Mass General Brigham’s Gene and Cell Therapy Institute, and faculty member with the Department of Stem Cell and Regenerative Biology at Harvard University. His research will leverage mRNA therapies and cell state targeting technologies (RADARS) to achieve mRNA tumor-specific therapies. RADARS enables the targeted expression of genetic payloads based on transcriptional state of tumor cells, reducing the risks of side effects and enhancing treatment efficacy with the potential to revolutionize cancer immunotherapy.